SCHEMBL10000293

SCHEMBL10000293

O=NCC(O)CN=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10048310 0.83
SCHEMBL2630683 0.83
SCHEMBL24080847 0.81
SCHEMBL28145590 0.81
SCHEMBL22197304 0.81
SCHEMBL3360241 0.81
SCHEMBL12642788 0.81
SCHEMBL9814886 0.81
SCHEMBL528388 0.77
SCHEMBL12418360 0.76

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115261834-A Method and touch screen device for reducing optical reflectivity of copper and copper alloy circuits 德国艾托特克公司 2022-11-01 CN disclosed
US-20150183737-A1 COMPOSITIONS AND METHODS FOR SUBSTRATE-SELECTIVE INHIBITION OF ENDOCANNABINOID OXYGENATION NATIONAL INSTITUTES OF HEALTH - DIRECTOR DEITR 2015-07-02 US disclosed
US-8741567-B2 Composition and methods related to modification of 5-hydroxymethylcytosine (5-hmC) THE UNIVERSITY OF CHICAGO (US) 2014-06-03 US disclosed
US-8097141-B2 Flow dielectrophoretic separation of single wall carbon nanotubes WILLIAM MARSH RICE UNIVERSITY (US) 2012-01-17 US disclosed
US-20100075934-A1 5-LIPOXYGENASE ACTIVATING PROTEIN (FLAP) INHIBITOR AMIRA PHARMACEUTICALS, INC. (US) 2010-03-25 US disclosed
EP-0909277-B2 HUMANIZED ANTIBODIES THAT BIND TO THE SAME ANTIGEN AS BOUND BY ANTIBODY NR-LU-13, AND THEIR USE IN PRETARGETING METHODS PONIARD PHARMACEUTICALS INC (US) 2008-12-24 EP disclosed
US-7247611-B2 Compositions and methods for promoting internalization and degradation of urokinase-type plasminogen activator THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA (US) 2007-07-24 US disclosed